News | February 23, 2022
GSK introduces Haleon to the world
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
He will continue to lead business in LATAM and Asia regions in this new role
Appoints Dr Rafiq Hasan as CEO
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
Subscribe To Our Newsletter & Stay Updated
